A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.

Gujarat Biotechnology Research Centre (GBRC) has successfully transferred three innovative technologies to private firms, aiming to improve the identification and treatment of hereditary cancers and ...